EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering the Pathogenicity of the PMS2 p.His701Gln Variant in a Family with Elderly-Onset Extracolonic Lynch Syndrome

Erica Candela, Giovanna Forte, Matteo Iacoviello iD, Antonia Lucia Buonadonna iD, Anna Maria Valentini iD, Martina Lepore Signorile iD, Paola Sanese, Katia De Marco, Andrea Manghisi iD, Nicoletta Maria Tutino, Emanuele Tatò, Candida Fasano und 3 weitere

Cells · 31.10.2026 · 15 (21) · 1990

DOI: 10.3390/cells15211990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 31.10.2026. Verfasst von Erica Candela und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics, National Institute of Gastroenterology, IRCCS "Saverio de Bellis" Research Hospital, 70013 Bari, Italy. Hauptthemen laut MEDLINE: Mismatch Repair Endonuclease PMS2, Colorectal Neoplasms, Hereditary Nonpolyposis. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Missense variants in PMS2 remain difficult to interpret in Lynch Syndrome (LS), particularly when clinical evidence is limited. We investigated the PMS2, NM_000535.7: c.2103T>A; p.His701Gln (p.H701Q) variant, currently classified as a variant of uncertain significance (VUS), identified in a 71-year-old patient with small intestinal adenocarcinoma. To clarify its clinical significance, we combined clinical, in silico, and functional analyses. Computational predictions consistently pointed to a deleterious effect, with AlphaMissense assigning a highly damaging score and most independent predictors supporting the same interpretation. H701Q affects the highly conserved C-terminal region of PMS2, close to the functionally critical Glu705 residue. In HEK-293T cells, PMS2-H701Q showed markedly reduced protein levels compared with wild-type PMS2, supporting an effect on protein stability. Co-immunoprecipitation experiments further showed a substantial reduction in the interaction between PMS2-H701Q and MLH1, indicating impaired MutLα complex formation. Both effects were comparable to those observed for the pathogenic PMS2-E705K control. Overall, the agreement between computational and functional findings provides compelling evidence for a deleterious effect of H701Q and strengthens its clinical interpretation. Collectively, these findings demonstrate the utility of functional evidence under the ClinGen-InSiGHT PMS2-specific ACMG/AMP variant classification guidelines and support reclassifying the PMS2, NM_000535.7: c.2103T>A; p.His701Gln (p.H701Q) variant from a Variant of Uncertain Significance (VUS) to likely pathogenic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mismatch Repair Endonuclease PMS2Colorectal Neoplasms, Hereditary NonpolyposisHumansHEK293 CellsAgedMaleFemalePedigreeAge of OnsetMutation, MissenseAmino Acid Sequence

Stichwörter der Autor:innen

LS spectrum of germline variantsLS-associated malignancyLynch SyndromePMS2PMS2 c.2103T>Aautosomal dominant cancer predisposition syndromelate-onset small bowel adenocarcinomap.His701Gln (p.H701Q)variants of uncertain significance (VUS)

Substanzen

Mismatch Repair Endonuclease PMS2PMS2 protein, human

Autor:innen und Institutionen

  • Medical Genetics, National Institute of Gastroenterology, IRCCS "Saverio de Bellis" Research Hospital, 70013 Bari, Italy.
  • Department of Molecular Medicine, University of Rome La Sapienza, 00161 Rome, Italy.
  • Histopathology Unit, National Institute of Gastroenterology, IRCCS "Saverio de Bellis" Research Hospital, 70013 Bari, Italy.
  • Medical Direction, National Institute of Gastroenterology, IRCCS "Saverio de Bellis", Research Hospital, 70013 Bari, Italy.
  • Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, 70124 Bari, Italy.

ORCID-Profile: Matteo Iacoviello, Antonia Lucia Buonadonna, Anna Maria Valentini, Martina Lepore Signorile, Andrea Manghisi, Valentina Grossi

Förderung

  • Ministero della Salute

Zitieren

APA

Candela, E., Forte, G., Iacoviello, M., Buonadonna, A. L., Valentini, A. M., Signorile, M. L., Sanese, P., Marco, K., Manghisi, A., Tutino, N. M., Tatò, E., Fasano, C., Disciglio, V., Grossi, V., & Simone, C. (2026). Deciphering the Pathogenicity of the PMS2 p.His701Gln Variant in a Family with Elderly-Onset Extracolonic Lynch Syndrome. Cells, 15(21), 1990. https://doi.org/10.3390/cells15211990

Vancouver

Candela E, Forte G, Iacoviello M, Buonadonna AL, Valentini AM, Signorile ML, et al. Deciphering the Pathogenicity of the PMS2 p.His701Gln Variant in a Family with Elderly-Onset Extracolonic Lynch Syndrome. Cells. 2026;15(21):1990. doi:10.3390/cells15211990

BibTeX
@article{Candela2026,
  author = {Candela, Erica and Forte, Giovanna and Iacoviello, Matteo and Buonadonna, Antonia Lucia and Valentini, Anna Maria and Signorile, Martina Lepore and Sanese, Paola and Marco, Katia De and Manghisi, Andrea and Tutino, Nicoletta Maria and Tatò, Emanuele and Fasano, Candida and Disciglio, Vittoria and Grossi, Valentina and Simone, Cristiano},
  title = {Deciphering the Pathogenicity of the PMS2 p.His701Gln Variant in a Family with Elderly-Onset Extracolonic Lynch Syndrome},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {1990},
  doi = {10.3390/cells15211990}
}
Kostenlos starten →